Skip to main content
SpringerLink
Log in

PET/MRI

  • Chapter
  • First Online:
Imaging in Pediatric Oncology

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

PET/MRI is a relatively new hybrid imaging modality that is mainly used for oncologic imaging. The combination of MRI and PET in a single examination is of high potential value especially in pediatric oncologic imaging due to the combination of precise morphologic and metabolic imaging, relatively low radiation exposure, and the potential avoidance of additional imaging studies. The technical complexity of PET/MRI requires multidisciplinary expertise in preparing and performing the examination as well as in image analysis.

PET/MR in children can be performed whenever a PET is indicated, and no contraindications against MRI are present. Thus, PET/MRI can be used for staging, therapy response assessment, and follow-up in children with lymphoma, sarcoma, neuroblastoma, CNS tumors, and cancer predisposition syndromes.

In this chapter we will give an overview of technical aspects of PET/MR imaging, review practical aspects related to performing pediatric PET/MR, and present a discussion of potential clinical as well as scientific applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, Schwaiger M, Ziegler SI. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52(12):1914–22.

    Article  Google Scholar 

  2. Schafer JF, Gatidis S, Schmidt H, Guckel B, Bezrukov I, Pfannenberg CA, Reimold M, Ebinger M, Fuchs J, Claussen CD, Schwenzer NF. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology. 2014;273(1):220–31.

    Article  Google Scholar 

  3. Gatidis S, Schmidt H, Gucke B, Bezrukov I, Seitz G, Ebinger M, Reimold M, Pfannenberg CA, Nikolaou K, Schwenzer NF, Schafer JF. Comprehensive oncologic imaging in infants and preschool children with substantially reduced radiation exposure using combined simultaneous (18)F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: a direct comparison to (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. Invest Radiol. 2016;51(1):7–14.

    Google Scholar 

  4. Pfluger T, Melzer HI, Mueller WP, Coppenrath E, Bartenstein P, Albert MH, Schmid I. Diagnostic value of combined (18)F-FDG PET/MRI for staging and restaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2012;39(11):1745–55.

    Google Scholar 

  5. Gatidis S, Bender B, Reimold M, Schafer JF. PET/MRI in children. Eur J Radiol. 2017;94:A64.

    Article  Google Scholar 

  6. Levin CS, Maramraju SH, Khalighi MM, Deller TW, Delso G, Jansen F. Design features and mutual compatibility studies of the time-of-flight PET capable GE SIGNA PET/MR system. IEEE Trans Med Imaging. 2016;35(8):1907–14.

    Article  Google Scholar 

  7. Bezrukov I, Schmidt H, Gatidis S, Mantlik F, Schafer JF, Schwenzer N, Pichler BJ. Quantitative evaluation of segmentation- and atlas-based attenuation correction for PET/MR on pediatric patients. J Nucl Med. 2015;56(7):1067–74.

    Article  Google Scholar 

  8. Hofmann M, Pichler B, Scholkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging. 2009;36(Suppl 1):S93–104.

    Article  Google Scholar 

  9. Brendle CB, Schmidt H, Fleischer S, Braeuning UH, Pfannenberg CA, Schwenzer NF. Simultaneously acquired MR/PET images compared with sequential MR/PET and PET/CT: alignment quality. Radiology. 2013;268(1):190–9.

    Article  Google Scholar 

  10. Wurslin C, Schmidt H, Martirosian P, Brendle C, Boss A, Schwenzer NF, Stegger L. Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med. 2013;54(3):464–71.

    Article  Google Scholar 

  11. Gatidis S, Schmidt H, la Fougere C, Nikolaou K, Schwenzer NF, Schafer JF. Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI. Eur J Nucl Med Mol Imaging. 2016;43:2283.

    Article  CAS  Google Scholar 

  12. Aghighi M, Pisani LJ, Sun Z, Klenk C, Madnawat H, Fineman SL, Advani R, Von Eyben R, Owen D, Quon A, Moseley M, Daldrup-Link HE. Speeding up PET/MR for cancer staging of children and young adults. Eur Radiol. 2016;26(12):4239–48.

    Article  Google Scholar 

  13. Klenk C, Gawande R, Tran VT, Leung JT, Chi K, Owen D, Luna-Fineman S, Sakamoto KM, McMillan A, Quon A, Daldrup-Link HE. Progressing toward a cohesive pediatric 18F-FDG PET/MR protocol: is administration of gadolinium chelates necessary? J Nucl Med. 2016;57(1):70–7.

    Article  CAS  Google Scholar 

  14. Gatidis S, Guckel B, la Fougere C, Schmitt J, Schafer JF. Simultaneous whole-body PET-MRI in pediatric oncology: more than just reducing radiation? Radiologe. 2016;56(7):622–30.

    Article  CAS  Google Scholar 

  15. Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Simonitsch-Klupp I, Raderer M, Mayerhoefer ME. Bone marrow involvement in malignant lymphoma: evaluation of quantitative PET and MRI biomarkers. Acad Radiol. 2017;25:453.

    Article  Google Scholar 

  16. Tzeng CW, Smith JK, Heslin MJ. Soft tissue sarcoma: preoperative and postoperative imaging for staging. Surg Oncol Clin N Am. 2007;16(2):389–402.

    Article  Google Scholar 

  17. Byun BH, Kong CB, Park J, Seo Y, Lim I, Choi CW, Cho WH, Jeon DG, Koh JS, Lee SY, Lim SM. Initial metabolic tumor volume measured by 18F-FDG PET/CT can predict the outcome of osteosarcoma of the extremities. J Nucl Med. 2013;54(10):1725–32.

    Article  CAS  Google Scholar 

  18. Rauscher I, Eiber M, Furst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT. J Nucl Med. 2014;55(5):724–9.

    Article  CAS  Google Scholar 

  19. Lee JW, Cho A, Yun M, Lee JD, Lyu CJ, Kang WJ. Prognostic value of pretreatment FDG PET in pediatric neuroblastoma. Eur J Radiol. 2015;84(12):2633–9.

    Article  Google Scholar 

  20. Goo HW. Whole-body MRI of neuroblastoma. Eur J Radiol. 2010;75(3):306–14.

    Article  Google Scholar 

  21. Dubois SG, et al. MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2017;64(11) https://doi.org/10.1002/pbc.26545.

  22. Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis. J Nucl Med. 2011;52(4):519–25.

    Article  CAS  Google Scholar 

  23. Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clin Cancer Res. 2014;20(8):2182–91.

    Article  CAS  Google Scholar 

  24. Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors. J Nucl Med. 2011;52(12):1864–70.

    Article  CAS  Google Scholar 

  25. Sawicki LM, Deuschl C, Beiderwellen K, Ruhlmann V, Poeppel TD, Heusch P, Lahner H, Fuhrer D, Bockisch A, Herrmann K, Forsting M, Antoch G, Umutlu L. Evaluation of (68)Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with (68)Ga-DOTATOC PET/CT. Eur Radiol. 2017;27(10):4091–9.

    Article  Google Scholar 

  26. Warbey VS, Ferner RE, Dunn JT, Calonje E, O’Doherty MJ. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging. 2009;36(5):751–7.

    Article  CAS  Google Scholar 

  27. Tsai LL, Drubach L, Fahey F, Irons M, Voss S, Ullrich NJ. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. J Neurooncol. 2012;108(3):469-75. https://doi.org/10.1007/s11060-012-0840-5.

  28. Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, Ishiguro N. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol. 2010;194(6):1568–74.

    Article  Google Scholar 

  29. Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MLC, Hansford JR, Janeway KA, Kohlmann WK, Mcgee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res. 2017;23(11):E38–45.

    Article  CAS  Google Scholar 

  30. Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol. 2013;48(5):295–301.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Imaging, Department of Radiology, University Hospital Tübingen, Tübingen, Germany

    Sergios Gatidis & Jürgen F. Schäfer

Authors
  1. Sergios Gatidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen F. Schäfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergios Gatidis .

Editor information

Editors and Affiliations

  1. Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

    Stephan D. Voss

  2. Department of Radiology, Great Ormond Street Hospital for Children, London, UK

    Kieran McHugh

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gatidis, S., Schäfer, J.F. (2019). PET/MRI. In: Voss, S., McHugh, K. (eds) Imaging in Pediatric Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-03777-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-03777-2_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-03776-5

  • Online ISBN: 978-3-030-03777-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation